These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 10316797)
21. Implementation of the mutual recognition agreement between the United States and the European Community; pharmaceutical GMP's and medical devices; establishment of a public docket and FDA contact points. Food and Drug Administration, HHS. Establishment of a public docket and FDA contact points. Fed Regist; 1999 Mar; 64(45):11376-7. PubMed ID: 10557625 [TBL] [Abstract][Full Text] [Related]
22. Getting SMART (submission management and review tracking) drug review in the computer age. Flieger K FDA Consum; 1995 Oct; 29(8):6-9. PubMed ID: 10151839 [TBL] [Abstract][Full Text] [Related]
23. Applications for Food and Drug Administration application approval to market a new drug; revision of postmarketing reporting requirements. Final rule. Food and Drug Administration, HHS Fed Regist; 2007 Oct; 72(201):58993-9000. PubMed ID: 17966558 [TBL] [Abstract][Full Text] [Related]
24. Quality assurance for medical products: unified program for all federal agencies. Flaherty FJ Hosp Formul; 1976 Dec; 11(12):669, 674, 679. PubMed ID: 1028796 [No Abstract] [Full Text] [Related]
25. FDA electronic drug labels to improve patient safety. J Pain Palliat Care Pharmacother; 2006; 20(2):96-7. PubMed ID: 16789334 [No Abstract] [Full Text] [Related]
26. A drug problem reporting system for Canadian hospital pharmacies. Friedel H; Gibson C Can J Hosp Pharm; 1978; 31(6):205-6. PubMed ID: 10240006 [No Abstract] [Full Text] [Related]
35. The drug efficacy study. Provost GP Am J Hosp Pharm; 1968 Sep; 25(9):483. PubMed ID: 5671558 [No Abstract] [Full Text] [Related]
36. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century. Kweder SL Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):605-9. PubMed ID: 18704917 [No Abstract] [Full Text] [Related]
37. The drug-potency question. Walker JM US Navy Med; 1974 Aug; 64(2):26-30. PubMed ID: 4534296 [No Abstract] [Full Text] [Related]
38. Products in the U.S. pipeline. Pharmaceutical Manufacturers Association. Biotechnology (N Y); 1991 Oct; 9(10):947-9. PubMed ID: 1367805 [No Abstract] [Full Text] [Related]
39. Providing drug information to health professionals and consumers: role and responsibility of the pharmaceutical manufacturer. Boyland JI Hosp Pharm; 1983 Apr; 18(4):211-3, 216. PubMed ID: 10260207 [TBL] [Abstract][Full Text] [Related]
40. Public standards for drugs: reflections on their use by the professions and industry. Miller LC Hosp Formul; 1976 Mar; 11(3):151-5. PubMed ID: 1026682 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]